Core Insights - Tai Chi Group's subsidiary Southwest Pharmaceutical has had its application for the generic version of Atomoxetine Hydrochloride Capsules accepted, with the original product set to cease supply in the Chinese market by January 2024 [1][2] - Atomoxetine, originally developed by Eli Lilly, is a non-stimulant medication recommended for treating ADHD in children and adolescents, with significant sales growth in the Chinese market [2][4] Company Developments - Southwest Pharmaceutical is currently the only company actively pursuing a 4th category new registration for the generic version of Atomoxetine Hydrochloride Capsules [4] - The company has increased its investment in the neuropsychiatric drug sector, with total R&D expenditure rising from 14.6 million to 28.2 million yuan from 2021 to 2024, representing an increase in revenue proportion from 1.20% to 2.28% [13][15] Market Context - The total sales of neuropsychiatric drugs in the hospital market are projected to exceed 110 billion yuan in 2024, with major market players including Renfu (21.31% market share), Shiyao Group (16.8%), and Yangtze River Pharmaceutical (approximately 13%) [4] - In 2021, the sales of Atomoxetine Hydrochloride Capsules in the full-terminal hospital market surpassed 300 million yuan, reflecting a year-on-year growth rate of 46.64% [2][4]

Market Overview - The Chinese medicine sector experienced a decline of 0.36% on September 25, with Enwei Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Stock Performance - Notable gainers included: - Weikang Pharmaceutical, closing at 25.25 with a rise of 9.83% and a trading volume of 135,600 shares, totaling 329 million yuan [1] - Yisheng Pharmaceutical, closing at 7.98 with a rise of 1.53% and a trading volume of 80,000 shares, totaling 6.41 million yuan [1] - Major decliners included: - Enwei Pharmaceutical, closing at 32.25 with a drop of 3.09% and a trading volume of 8,950 shares, totaling 2.91 million yuan [2] - Zhendong Pharmaceutical, closing at 6.85 with a drop of 2.97% and a trading volume of 508,400 shares [2] Capital Flow - The Chinese medicine sector saw a net outflow of 462 million yuan from institutional investors, while retail investors contributed a net inflow of 315 million yuan [2] - The table of capital flow indicates that: - Wanbangde had a net inflow of 23.44 million yuan from institutional investors, but a net outflow of 29.29 million yuan from retail investors [3] - Jilin Aodong experienced a net inflow of 21.10 million yuan from institutional investors, with outflows from both retail and speculative investors [3]

Core Viewpoint - Four listed companies conducted stock buybacks on September 24, with significant amounts and quantities involved [1] Group 1: Company Buyback Details - Taiji Group had the highest buyback amount, reaching 110 million yuan, with a total of 5.02 million shares repurchased [1] - Zhaoxun Media repurchased shares worth 48.18 million yuan, totaling 4.21 million shares [1] - Hunan Haili's buyback amounted to 17.43 million yuan, with 2.49 million shares repurchased [1]

Core Viewpoint - Taiji Group has completed a share buyback of 5,472,559 shares, which will be used for cancellation and reduction of registered capital, with no change in the controlling shareholder or actual controller [1][2] Summary by Sections Share Buyback Details - As of September 22, Taiji Group has repurchased 5,472,559 shares, accounting for 0.98% of the total share capital [1] - The maximum buyback price was set at 28.03 CNY per share, with a total buyback fund between 80 million CNY and 120 million CNY [1] - The actual buyback was completed at an average price of 21.92 CNY per share, totaling 120 million CNY including transaction fees, reaching the upper limit of the buyback plan [1] Impact on Shareholding Structure - After the cancellation of the repurchased shares, the combined shareholding ratio of the controlling shareholder and its concerted parties will increase from 29.82% to 30.12% without changing the controlling shareholder or actual controller [2]

Core Viewpoint - The company has successfully completed a share buyback, resulting in a change in the shareholding structure of its controlling shareholder without altering control dynamics [2][5][10]. Buyback Approval and Plan - The company approved a share buyback plan on July 16 and August 6, 2025, allowing for the repurchase of shares at a price not exceeding 28.03 CNY per share, with a total fund allocation between 80 million and 120 million CNY [3][4]. - The buyback period is set from August 6, 2025, to August 5, 2026 [3]. Buyback Implementation - As of September 22, 2025, the company repurchased 5,472,559 shares, accounting for 0.98% of the total share capital, with a total expenditure of 120 million CNY [4][5]. - The buyback was executed in accordance with the disclosed plan, and the average repurchase price was 21.92 CNY per share [4][5]. Share Cancellation Arrangement - The repurchased shares will be canceled, reducing the registered capital of the company, and the cancellation process was initiated on September 24, 2025 [9][11]. - No objections were raised by creditors during the notification period regarding the share buyback [9]. Shareholding Changes - Following the cancellation of shares, the total number of shares will decrease from 556,890,744 to 551,418,185 [10]. - The controlling shareholder's stake will increase from 29.82% to 30.12% without any change in the number of shares held, thus not affecting the control of the company [2][10].

Core Viewpoint - Tai Chi Group (600129) announced the completion of its share repurchase on September 22, 2025, having repurchased a total of 5,472,559 shares, which represents 0.98% of the company's total share capital [1] Summary by Category - **Company Actions** - The company has successfully completed a share repurchase program, acquiring 5,472,559 shares [1] - The repurchased shares account for 0.98% of the total share capital of the company [1]

证券代码：600129 证券简称：太极集团 公告编号：2025-073 重庆太极实业（集团）股份有限公司 关于股份回购实施结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 重要内容提示： | | --- | | 回购方案首次披露日 | 2025/7/16，由董事会提议 | | | | | | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 年 日~2026 月 2025 6 8 5 | 8 | 月 | 年 | 日 | | 预计回购金额 | 8,000万元~12,000万元 | | | | | | 回购价格上限 | 28.03元/股 | | | | | | 回购用途 | √减少注册资本 □用于员工持股计划或股权激励 | | | | | | | □为维护公司价值及股东权益 | | | | | | 实际回购股数 | 5,472,559股 | | | | | | 实际回购股数占总股本比例 | 0.98% | | | | | | 实际回购金额 | 12,000.0 ...

Core Viewpoint - Taiji Group (600129.SH) has completed a share buyback, acquiring a total of 5.4726 million shares, which represents 0.98% of the company's total share capital [1] Summary by Categories Share Buyback Details - The company completed the buyback on September 22, 2025, with a maximum purchase price of 22.36 CNY per share and a minimum price of 21.46 CNY per share [1] - The average buyback price was 21.92 CNY per share, with a total expenditure of 120 million CNY, including transaction commissions and other fees [1]

Core Viewpoint - Tai Chi Group's stock has experienced a decline in both price and trading volume, reflecting a challenging financial performance in recent periods [1][2]. Group 1: Stock Performance - On September 22, Tai Chi Group's stock price fell by 2.03%, reaching 21.23 CNY per share, with a trading volume of 1.60 billion CNY and a market capitalization of 118.23 billion CNY [1]. - Year-to-date, the stock price has decreased by 14.12%, with a 1.80% drop over the last five trading days, a 10.46% decline over the last 20 days, and a slight decrease of 0.38% over the last 60 days [1]. Group 2: Financial Performance - For the first half of 2025, Tai Chi Group reported a revenue of 5.658 billion CNY, representing a year-on-year decrease of 27.63%, and a net profit attributable to shareholders of 139 million CNY, down 71.94% compared to the previous year [2]. - Cumulative cash dividends since the A-share listing amount to 483 million CNY, with 167 million CNY distributed over the last three years [3]. Group 3: Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 8.15% to 54,100, while the average circulating shares per person increased by 8.87% to 10,296 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 6.2524 million shares, a decrease of 880,600 shares, while the Southern CSI 1000 ETF is a new entrant with 3.6013 million shares [3].

Group 1 - The company, Chongqing Taiji Industrial (Group) Co., Ltd., will participate in the "Chongqing District 2025 Investor Online Collective Reception Day" event to enhance interaction with investors [1] - The event is scheduled for September 25, 2025, from 15:00 to 17:00, and investors can participate via the "Panjing Roadshow" website [1] - Company executives will engage in online communication with investors, addressing their concerns in a "one-to-many" format [1]